申请人:The Board of Trustees of the University of Illinois
公开号:US10323057B2
公开(公告)日:2019-06-18
Provided are certain derivatives of amphotericin B (AmB) characterized by reduced toxicity and retained anti-fungal activity. Certain of the derivatives are C16 urea derivatives of AmB. Certain of the derivatives are C3, C5, C8, C9, C11, C13, or C15 deoxy derivatives of AmB. Certain of the derivatives include C3′ or C4′ modifications of the mycosamine appendage of AmB. Also provided are methods of making AmB derivatives of the invention, pharmaceutical compositions comprising AmB derivatives of the invention, and methods of use of AmB derivatives of the invention.
本文提供了两性霉素 B(AmB)的某些衍生物,其特点是毒性降低,抗真菌活性保持不变。其中某些衍生物是 AmB 的 C16 脲衍生物。某些衍生物是 AmB 的 C3、C5、C8、C9、C11、C13 或 C15 脱氧核衍生物。某些衍生物包括 AmB 的霉菌胺附属物的 C3′或 C4′修饰。此外,还提供了制造本发明AmB衍生物的方法、包含本发明AmB衍生物的药物组合物以及本发明AmB衍生物的使用方法。